Videocast of Congressional Hearing: National Institutes of Health Budget Request for FY 2020. U.S. House of Representatives Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
Anthony S. Fauci, M.D., NIAID Director
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2019 is an estimated $5.5 billion.
Dr. Fauci has advised five Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
NIAID Director, Dr. Anthony Fauci.
Credit: NIAID
Profiles, Awards, and Honors
Publications and Articles
April 17, 2019
Measles in 2019 — Going Backward
Measles in 2019 — Going Backward
Dr. Fauci in the News
Congressional Testimony
The Role of the National Institutes of Health in Preparing for Emerging Infectious Disease Threats. Testimony before the Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
Videocast of Congressional Testimony from March 14, 2019
Laboratory of Immunoregulation
Dr. Fauci also is the long-time chief of the Laboratory of Immunoregulation (LIR). He has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response.